Font Size: a A A

Clinical Observation On Treatment Of Senile Non - Small Cell Lung Cancer With Spleen Yishen, Huayu Sanjie Combined With Paclitaxel Liposomes

Posted on:2016-01-28Degree:MasterType:Thesis
Country:ChinaCandidate:Y XiaoFull Text:PDF
GTID:2134330467981779Subject:Internal medicine of traditional Chinese medicine
Abstract/Summary:PDF Full Text Request
Objective:Observe clinical effect of Jianpi Wenshen Huayu Sanjie Recipe combined chemotherapy in the treatment of elderly advanced non small cell lung cancer patients,using the cancer objective efficiency, clinical symptoms, physical condition Karnofsky score, weight, cellular immune function and the side effects of chemotherapy for detecting indexes to evaluate the effect ofJianpi Wenshen Huayu Sanjie Recipe for treatment of elderly advanced non small cell lung cancer.Methods:Using a randomized controlled method,60definite Patients with elderly advanced non small cell lung cancer have been Assigned into two groups,30in the test group,30in the control group. Patients in the test group receive Chinese medicine combined chemotherapy, patients in the control group receive chemotherapy only.21days is a treatment course. They were observed for two treatment courses. Comparison of two groups of patients in the cancer objective efficiency, clinical symptoms, physical condition Karnofsky score, weight, cellular immune function and the side effects of chemotherapy and other aspects of the clinical benefits.Results:After treatment, the test group displayed more effective on ameliorating clinical symptoms, enhancing the physical strength (Karnofsky score), increasing body weight, improving cellular immune function and reducing the chemotherapy poisonous side reaction. Showing significant difference between the two groups(p<0.05). But after treatment, comparing the Cancer short-term objective efficacy in two groups of patients, efficiency(CR+PR)were33.33%and33.00%, disease control rate(CR+PR+SD)in the2groups were73.33%and70.00%, there was no significant difference between the two groups(p>0.05).Conclusion:In this research Chinese medicine for the treatment of elderly advanced non small cell lung cancel can ameliorate clinical symptoms, enhance the physical strength(Karnofsky score), and increase and maintain body weight, improve cellular immune function in a certain extent. There is few adverse effect of Jianpi Wenshen Huayu Sanjie Recipe, which deserve spreading its clinical application.
Keywords/Search Tags:elderly non small cell lung cancer, Traditional Chinesemedicine treatment, chemotherapy, clinical research
PDF Full Text Request
Related items
Observation On The Therapeutic Effect Of Traditional Chinese Medicine Protective Therapy Combined With Chemotherapy On Non - Small Cell Lung Cancer
Clinical Study On Maintenance Treatment Of Advanced Non - Small Cell Lung Cancer By Traditional Chinese Medicine
The Clinical Research Of Qizhi Guben Fang Combined With TP Scheme In Treating Patients Of Advanced Non Small Cell Lung Cancer
Clinical Research Of The Treatment Of Regulating Qi And Strengthening Spleen Combined Chemotherapy On The Patients Of Mediun Or Late Non-small Cell Lung Cancer (NSCLC)
Re-study On Clinical Efficacy Of Traditional Chinese Medicine Combined With Chemotherapy In Advanced Non-small Cell Lung Cancer
Clinical Research Of CDDP-based Two-agent Combination Chemotherapy On Elderly Patients With Advanced Non-small Cell Lung Cancer
Comparing Doublet And Single Cytotoxic Agent Chemotherapy As First-line Treatment In Elderly Patients With Advanced Non Small-cell Lung Cancer Efficacy And Safety Analysis
The Clinical Research Of Chinese Traditional Syndrome Between Before And After The Chemotherapy Treatment Of PP In Advanced Non-small Cell Lung Cancer
Yifei Spleen, Phlegm And Blood Stasis Method Combined With Cisplatin-based Third-generation Chemotherapy Regimens For Treatment Of Advanced Non-small Cell Lung Cancer Clinical Research
10 A Clinical Study Of Gufei Xiaoji Decoction Combined With Bronchial Arterial Chemotherapy Infusion Therapy For Elderly Locally Advanced Non-small Cell Lung Cancer